Abeona therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Abeona therapeutics Contact Number

Contacts :: Abeona Therapeutics Inc. (ABEO)

9 hours ago Investors.abeonatherapeutics.com Show details

Investor Relations. [email protected]abeonatherapeutics.com. © 2022 Abeona Therapeutics Inc. All Rights Reserved. Privacy PolicyPrivacy Policy

Category: Contact SupportShow more

Abeona Therapeutics Crunchbase Company Profile & …

9 hours ago Crunchbase.com Show details

Contact Email [email protected]abeonatherapeutics.com. Phone Number (216)287-5408. Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell

Founders: Douglas McCarty, Haiyan Fu

Category: Contact NumberShow more

Abeona Therapeutics Inc. (ABEO)

5 hours ago Abeonatherapeutics.com Show details

ABO-101. In Phase 1/2 development. One-time, AAV-based gene therapy for patients with Sanfilippo syndrome type B (MPS IIIB). Learn More.

Category: Contact NumberShow more

Abeona Therapeutics Inc. Company Profile New York, NY

7 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Abeona Therapeutics Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.

Employees: 42
Tangible Fixed Assets: $18
Intangible Assets: $2
Location: 1330 Avenue OF The Americas FL 33, New York, 10019-5442, NY

Category: Contact NumberShow more

Company Information :: Abeona Therapeutics Inc. (ABEO)

Just Now Investors.abeonatherapeutics.com Show details

Company Contact Abeona Therapeutics Inc. 1330 Avenue of the Americas 33rd Floor New York, NY 10019

Category: Contact NumberShow more

Abeona Therapeutics LLC Company Profile Cleveland, …

7 hours ago Dnb.com Show details

Company Description: Abeona Therapeutics LLC is located in Cleveland, OH, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Abeona Therapeutics LLC has 1 total employees across all of its locations and generates $2.29 million in sales (USD).

Category: Contact NumberShow more

Abeona Therapeutics Company Profile Office Locations

6 hours ago Craft.co Show details

Abeona Therapeutics has 88 employees across 4 locations and $10 M in annual revenue in FY 2020. See insights on Abeona Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Abeona Therapeutics Issues Letter to Shareholders

2 hours ago Finance.yahoo.com Show details

(646) 813-4709CONTACT: Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709 [email protected] Recommended Stories Yahoo Finance

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. (Form: 8K, Received: 09/21/2021

8 hours ago Content.edgar-online.com Show details

152-21-0232ABEONA THERAPEUTICS INC. (Exact name of registrant as specified in its charter) Delaware 001-15771 83-0221517 (State or other jurisdiction of incorporation) (Commission. File Number) (I.R.S. Employer. Identification No.) 1330

Category: Contact NumberShow more

Abeona Therapeutics Issues Letter to Shareholders

1 hours ago Globenewswire.com Show details

(646) 813-4709Contact Data Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709

Category: Contact NumberShow more

Patients & Families :: Abeona Therapeutics Inc. (ABEO)

3 hours ago Abeonatherapeutics.com Show details

While costs vary based on the type and number of bandages, and wound size, the average cost of bandages for a 10-year-old child is approximately $120,000 per year. Abeona is developing an autologous, gene-corrected cell therapy for RDEB. We expect to initiate the pivotal Phase 3 VIITAL™ study evaluating EB-101 for the treatment of RDEB in Q1

Category: Contact NumberShow more

Abeona Therapeutics LinkedIn

1 hours ago Linkedin.com Show details

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The …

Category: Contact NumberShow more

Abeona Therapeutics Announces Pricing of Public Offering

Just Now Finance.yahoo.com Show details

(646) 813-4709CONTACT: Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709 [email protected] Recommended Stories Motley Fool

Category: Contact NumberShow more

Abeona Therapeutics Announces Public Offering of Common

1 hours ago Finance.yahoo.com Show details

(646) 813-4709CONTACT: Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709 [email protected] Recommended Stories MoneyWise

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. (Form: 8K, Received: 04/19/2021

8 hours ago Content.edgar-online.com Show details

152-21-0091ABEONA THERAPEUTICS INC. (Exact name of registrant as specified in its charter) Delaware 001-15771 83-0221517 (State or other jurisdiction. of incorporation) (Commission. File Number) Investor and Media Contact: Greg Gin

Category: Contact NumberShow more

About :: Abeona Therapeutics Inc. (ABEO)

Just Now Abeonatherapeutics.com Show details

About. Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. Our expertise across R&D, manufacture, and discovery of novel gene and cell therapies has us uniquely positioned to bring new medicines to patients in need.

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. (Form: DEF 14A, Received: 04/09

Just Now Content.edgar-online.com Show details

361-21-0123New York, NY 10019. 646-813-4701. April 9, 2021. To Our Stockholders: You are cordially invited to attend the Annual Meeting of Stockholders (the “Annual Meeting”) of Abeona Therapeutics Inc. (the “Company”) to be held virtually on Wednesday, May 26, 2021 at 9:00 a.m., Eastern Time.

Category: Contact NumberShow more

Abeona Therapeutics email format Abeona Therapeutics.com

2 hours ago Aeroleads.com Show details

Abeona Therapeutics Information Email formats, Phone Number, CEO CTO CFO COO CMO email of Abeona Therapeutics Location: 1330 Avenue …

Category: Contact NumberShow more

Abeona Therapeutics Reports Third Quarter Financial

6 hours ago Investors.abeonatherapeutics.com Show details

888-506-0062Abeona Therapeutics will host a conference call and webcast on Wednesday, November 17, 2021 at 8:30 a.m. ET, to discuss its third quarter 2021 financial results and business update. To access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 512059 five minutes prior to the start of the call.

Category: Contact NumberShow more

Careers :: Abeona Therapeutics Inc. (ABEO)

2 hours ago Abeonatherapeutics.com Show details

Headquarters Abeona Therapeutics Inc. 1330 Avenue of the Americas 33rd Floor New York, NY 10019 Abeona Cleveland Abeona Therapeutics Inc. 6555 Carnegie Avenue 4th Floor Cleveland, OH 44103 Abeona Madrid Abeona Therapeutics please contact us with your request. Determinations on requests for reasonable accommodation are made on a case-by …

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. (Form: 8K, Received: 03/30/2021

8 hours ago Content.edgar-online.com Show details

152-21-0071ABEONA THERAPEUTICS INC. (Exact name of registrant as specified in its charter) Delaware 001-15771 83-0221517 (State or other jurisdiction. of incorporation) (Commission. File Number) Investor and Media Contact: Greg Gin. VP, Investor Relations and Corporate Communications.

Category: Contact NumberShow more

Abeona Therapeutics Funding, Financials, Valuation

8 hours ago Crunchbase.com Show details

Abeona Therapeutics has raised a total of $232.2M in funding over 7 rounds. Their latest funding was raised on Dec 28, 2019 from a Post-IPO Equity round. Abeona Therapeutics is registered under the ticker NASDAQ:ABEO . Abeona Therapeutics is funded by 8 investors. Jefferies and H. C. Wainwright & Co. are the most recent investors.

Category: Contact NumberShow more

Abeona Therapeutics LLC Company Profile and News

3 hours ago Bloomberg.com Show details

Company profile page for Abeona Therapeutics LLC including stock price, company news, press releases, executives, board members, and contact information

Category: Contact NumberShow more

Abeona Therapeutics Issues Letter to Shareholders BioSpace

2 hours ago Biospace.com Show details

(646) 813-4709Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709 …

Category: Contact NumberShow more

Abeona Therapeutics Reports Third Quarter Financial Results

7 hours ago Finance.yahoo.com Show details

About Abeona Therapeutics Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Weighted average number of common. shares outstanding – basic and

Category: Contact NumberShow more

MidDay Market Update: Dow Tumbles 500 Points; Abeona

8 hours ago Markets.businessinsider.com Show details

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,435,650 cases with around 824,520 deaths. Dow Tumbles 500 Points; Abeona Therapeutics

Category: Contact NumberShow more

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest

6 hours ago Marketbeat.com Show details

Abeona Therapeutics Inc (NASDAQ:ABEO) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 906,400 shares, a decrease of 57.0% from the November 15th total of 2,110,000 shares. Currently, 1.0% of the company's stock are sold short. Based on an average daily volume of 781,500 shares, …

Category: Contact NumberShow more

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest

2 hours ago Marketbeat.com Show details

Abeona Therapeutics Inc (NASDAQ:ABEO) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,340,000 shares, a growth of 47.8% from the November 30th total of 906,400 shares. Currently, 1.5% of the company's shares are sold short. Based on an average daily trading volume, of …

Category: Contact NumberShow more

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

1 hours ago Ih.advfn.com Show details

(646) 813-4701On October 24, 2014 we changed our name to PlasmaTech Biopharmaceuticals, Inc., and on June 19, 2015, we changed our name to Abeona Therapeutics Inc. to reflect our broader rare disease commitment. Our principal executive office is located at 1330 Avenue of the Americas, 33rd Floor, New York, NY 10019 and our telephone number is (646) 813-4701.

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. : Shareholders Board Members

4 hours ago Marketscreener.com Show details

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases.

Category: Contact NumberShow more

Investor Relations :: Abeona Therapeutics Inc. (ABEO)

Just Now Investors.abeonatherapeutics.com Show details

Investor Relations. Abeona Therapeutics is a clinical-stage biopharmaceutical company focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups.

Category: Contact NumberShow more

Abeona Therapeutics hiring Director, Program Lead in

Just Now Linkedin.com Show details

Posted 7:05:03 PM. Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel…See this and similar jobs on LinkedIn.

Category: Contact NumberShow more

MidDay Market Update: Dow Tumbles 500 Points; Abeona

3 hours ago Benzinga.com Show details

Abeona Therapeutics Inc. (NASDAQ: ABEO) was down, falling 37% to $0.3054 after the company reported pricing of public offering of common stock and warrants. In commodity news, oil traded down 2%

Category: Contact NumberShow more

Abeona Therapeutics Company Profile: Stock Performance

7 hours ago Pitchbook.com Show details

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno

Category: Contact NumberShow more

Abeona Therapeutics Number of Employees 20062021 ABEO

6 hours ago Macrotrends.net Show details

Abeona Therapeutics number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases.

Category: Contact NumberShow more

Abeona Therapeutics Announces Public Offering of Common

5 hours ago Marketscreener.com Show details

(646) 813-4709Investor and Media Contact: Greg Gin VP, Investor Relations and Corporate Communications Abeona Therapeutics +1 (646) 813-4709 [email protected] Source: Abeona Therapeutics Inc. 2021 GlobeNewswire, Inc., source Press Releases

Category: Contact NumberShow more

Abeona Therapeutics (ABEO) Recent Earnings

8 hours ago Earningswhispers.com Show details

888-506-0062Abeona Therapeutics will host a conference call and webcast on Wednesday, November 17, 2021 at 8:30 a.m. ET, to discuss its third quarter 2021 financial results and business update. To access the call, dial 888-506-0062 ( U.S. toll-free) or 973-528-0011 (international) and Entry Code: 512059 five minutes prior to the start of the call.

Category: Contact NumberShow more

Analysts Anticipate Abeona Therapeutics Inc (NASDAQ:ABEO

9 hours ago Marketbeat.com Show details

The company's fifty day simple moving average is $0.61 and its two-hundred day simple moving average is $1.01. Abeona Therapeutics has a 52 week low of $0.27 and a 52 week high of $3.79. The stock has a market cap of $31.68 million, a P/E ratio of -0.55 and a beta of 1.30. Abeona Therapeutics Company Profile. Abeona Therapeutics Inc, a clinical

Category: Contact NumberShow more

Abeona Therapeutics Inc. (NASDAQ: ABEO) Is A Blank Check

2 hours ago Stocksregister.com Show details

Abeona Therapeutics Inc. (NASDAQ:ABEO) shares, rose in value on Wednesday, 12/15/21, with the stock price up by 0.66% to the previous day’s close as strong demand from buyers drove the stock to $0.52. Actively observing the price movement in the last trading, the stock closed the session at $0.52,

Category: Contact NumberShow more

ABEONA THERAPEUTICS INC. : ABEO Stock Price US00289Y1073

6 hours ago Marketscreener.com Show details

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases. The Company’s lead clinical programs consist of EB-101, which is an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102, which is an

Category: Contact NumberShow more

What Direction Does Abeona Therapeutics Inc. (NASDAQ: ABEO

1 hours ago Stocksregister.com Show details

The number of analysts that have assigned ABEO a recommendation rating is 3. Out of them, 0 rate it a Hold, while 3 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Abeona Therapeutics Inc. (ABEO) as Underweight, while 0 advise Sell.

Category: Contact NumberShow more

Abeona Therapeutics Reports Second Quarter Financial

7 hours ago Investors.abeonatherapeutics.com Show details

888-506-0062Abeona Therapeutics will host a conference call and webcast on Thursday, July 29, 2021 at 8:30 a.m. ET, to discuss its second quarter 2021 financial results and business update. To access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 7184522 five minutes prior to the start of the call.

Category: Contact NumberShow more

Is Abeona Therapeutics Inc (ABEO) a Winner in the

4 hours ago Investorsobserver.com Show details

A rating of 76 puts Abeona Therapeutics Inc near the top of the Biotechnology industry according to InvestorsObserver.Abeona Therapeutics Inc's score of 76 means it scores higher than 76% of stocks in the industry. Abeona Therapeutics Inc also received an overall rating of 52, putting it above 52% of all stocks.

Category: Contact NumberShow more

Is Abeona Therapeutics Inc (ABEO) Stock at the Top of the

2 hours ago Investorsobserver.com Show details

Abeona Therapeutics Inc (ABEO) stock is trading at $0.34 as of 9:34 AM on Thursday, Dec 23, an increase of $0.01, or 3.69% from the previous closing price of $0.33. The stock has traded between $0.34 and $0.34 so far today. Volume today is less active than usual.

Category: Contact NumberShow more

Abeona Therapeutics hiring Manufacturing Associate in

2 hours ago Linkedin.com Show details

Apply for Manufacturing Associate at Abeona Therapeutics Contact info First name. Please enter a valid first name At least 6 characters including at least 1 number or 1 special character.

Category: Contact NumberShow more

Abeona Therapeutics (ABEO) to Offer Common Stock and Warrants

6 hours ago Streetinsider.com Show details

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it intends to offer and sell shares of its common stock and warrants to purchase

Category: Contact NumberShow more

Abeona Therapeutics, Inc. EverybodyWiki Bios & Wiki

8 hours ago En.everybodywiki.com Show details

Abeona Therapeutics, Inc. is a pharmaceutical development company. Its research focuses on developing treatments for rare diseases using gene therapy and human plasma-derived therapeutics. The company is trying to find ways to address Sanfilippo Syndrome, Fanconi anemia, and Juvenile Batten disease.

Category: Contact NumberShow more

Brendan M. O'Malley Net Worth, Biography & Insider Trading

8 hours ago Insidertrades.com Show details

214-665-9495How do I contact Brendan M. O'Malley? The corporate mailing address for Mr. O'Malley and other Abeona Therapeutics executives is 3333 LEE PARKWAY SUITE 600, DALLAS TX, 75219. Abeona Therapeutics can also be reached via phone at 214-665-9495 and via email at [email protected]

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is Abeona Therapeutics?

Abeona Therapeutics is focused on developing novel gene and cell therapy approaches for potential treatment of individuals impacted by rare diseases including Epidermolysis Bullosa, Sanfilippo Syndrome, and Batten Disease.

What is Abeona's pipeline?

Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM™ Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.

What does Abeona plan to do with the net proceeds?

Abeona intends to use the net proceeds of the offering to fund continued clinical development of pipeline products, as well as for working capital and corporate purposes.

Popular Brands

Amazon
Abbvie
Asml
Aia
Att
Apple
Amgen
Adobe
Aptar
Acc
Adidas
Aak